Acadia Pharmaceuticals
ACAD
ACAD
212 hedge funds and large institutions have $4.44B invested in Acadia Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
212
Holders Change
+9
Holders Change %
+4.43%
% of All Funds
5.29%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
34
Increased
67
Reduced
72
Closed
24
Calls
$44.1M
Puts
$71.4M
Net Calls
-$27.2M
Net Calls Change
-$16.3M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$78.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$27.3M |
| 3 |
SIG
Senator Investment Group
New York
|
$54.4M |
| 4 |
Millennium Management
New York
|
$2.32M |
| 5 |
State Street
Boston,
Massachusetts
|
$122M |
